Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Optimization of cytochrome P4502D6 (CYP2D6) phenotype assignment using a genotyping algorithm based on allele

A Gaedigk1, R R Gotschall, N S Forbes

  • 1Section of Pediatric Clinical Pharmacology and Experimental Therapeutics, The Children's Mercy Hospital, and University of Missouri-Kansas City, 64108, USA. agaedigk@cmh.edu

Pharmacogenetics
|January 14, 2000
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lean body weight dosing avoids excessive systemic exposure to proton pump inhibitors for children with obesity.

Pediatric obesity·2018
Same author

Review article: the physiological effects and safety of peppermint oil and its efficacy in irritable bowel syndrome and other functional disorders.

Alimentary pharmacology & therapeutics·2018
Same author

Pharmacogenetic comparison of CYP2D6 predictive and measured phenotypes in a South African cohort.

The pharmacogenomics journal·2017
Same author

Why has model-informed precision dosing not yet become common clinical reality? lessons from the past and a roadmap for the future.

Clinical pharmacology and therapeutics·2017
Same author

Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6 genotype and use of ondansetron and tropisetron.

Clinical pharmacology and therapeutics·2016
Same author

Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update.

Clinical pharmacology and therapeutics·2016

Accurate prediction of Cytochrome P4502D6 (CYP2D6) poor metabolizer status is possible with minimal genotyping. A streamlined approach using extra-long PCR and reamplification reactions achieves high accuracy efficiently.

Area of Science:

  • Pharmacogenomics
  • Molecular Biology
  • Genetics

Background:

  • Cytochrome P4502D6 (CYP2D6) exhibits significant genetic polymorphism, leading to variable drug metabolism.
  • Accurate prediction of CYP2D6 phenotype is crucial for personalized medicine but current genotyping methods can be complex and costly.

Purpose of the Study:

  • To determine the optimal amount of genotyping needed for cost-effective and accurate CYP2D6 phenotype prediction.
  • To develop an efficient genotyping strategy for identifying poor metabolizer phenotypes in a North American population.

Main Methods:

  • Developed a polymerase chain reaction (PCR)/restriction fragment length polymorphism (RFLP) strategy combined with extra-long PCR (XL-PCR).
  • Utilized a genotyping algorithm incorporating allele frequencies and phenotype data to calculate genotype assignment probabilities.

Related Experiment Videos

  • Tested the model in 208 white North Americans, analyzing key mutations and gene deletions associated with various CYP2D6 alleles.

    • Main Results:

    • A strategy using just one XL-PCR and up to six reamplification reactions predicted genotypes with 99.15% accuracy.
    • As few as four reamplification reactions identified 97.9% of poor metabolizer individuals.
    • Phenotype prediction was accurate for all tested individuals, with discrepancies attributed to drug interactions.

    Conclusions:

    • A streamlined genotyping approach significantly reduces the complexity and cost of CYP2D6 phenotype prediction.
    • This optimized method enables accurate identification of poor metabolizers, facilitating safer and more effective pharmacotherapy.
    • The findings support the implementation of efficient CYP2D6 genotyping in clinical practice.